Radiation Oncology at Hackensack Meridian Health in New Jersey

This technique enhances the diagnostic quality of simulation scans, the foundation of radiation planning, allowing for more precise treatment planning.

4DCT captures the movement of tumors during treatment, allowing for more accurate radiation targeting and minimizing side effects.

A noninvasive procedure that treats brain and skull base tumors with high-dose radiation. This procedure offers a safer alternative to traditional brain surgery, with unparalleled precision and fewer side effects.

How does Gamma Knife SRS work?

Gamma Knife SRS uses precisely targeted high-dose radiation beams to treat brain and skull base tumors, as well as other brain disorders including arteriovenous malformation, essential tremor and trigeminal neuralgia.

Treatment steps include:

• Fitting for a customized, lightweight head frame, if required. The head frame ensures that the radiation beams target the precise treatment area and help to keep the head still during the procedure.
• Hackensack Meridian Health also offers frameless Gamma Knife treatment - which does not require the use of a head frame - for select patients.
• Imaging using MRI or CT technology. Imaging scans determine the exact size, shape and position of the treatment area.
• Personalized treatment planning. Your physician will develop a treatment plan using a specially designed computer that calculates the best way to deliver the radiation treatment.
• Automated, painless treatment. The fully awake patient reclines on a moveable treatment table while the machine rotates to deliver radiation from various positions.
• Return to normal routines. Although some patients will need to stay overnight for observation, most can go home immediately and experience only minor side effects, if any.

What are the benefits of Gamma Knife?

The main benefit of Gamma Knife is that it can be a safer alternative to traditional “open” brain surgery or whole-brain radiation, which come with a higher risk of side effects or complications. Other benefits include:

• Noninvasive. No incisions are necessary, meaning that patients do not require general anesthesia and are not at risk of hemorrhage, infection, or other complications that can occur during open brain surgery.
• Enhanced efficiency. Unlike traditional radiation treatments, patients who receive Gamma Knife SRS typically require only one outpatient treatment. Exclusively used for treatment of the brain. Gamma Knife is the only SRS system specifically designed and optimized to treat brain lesions and disorders.
• Unparalleled accuracy. The Gamma Knife radiation beams conform to the shape of the lesion, delivering high-dose treatment with sub-millimeter accuracy.
• Fewer side effects. Gamma Knife’s precision spares healthy brain tissue from radiation exposure, reducing the risks of side effects. Many patients experience only mild side effects, or no side effects at all.

Commonly treated conditions include:

• Acoustic neuroma
• Arteriovenous malformation (AVM)
• Brain metastases
• Essential tremor
• Glioblastoma
• Meningioma
• Pituitary adenoma
• Trigeminal neuralgia
• Vestibular schwannoma

Locations

JFK University Medical Center 65 James Street Edison, NJ 08820 732-321-7540

Hackensack University Medical Center 30 Prospect Avenue Hackensack, NJ 07601 551-996-2000

This method positions patients face down for optimal radiation delivery, reducing exposure to healthy tissues and vital organs such as the heart and lungs.

This technique delivers higher doses of radiation over a shorter period, reducing the overall treatment duration.

Used primarily for skin or surface tumors, electron therapy provides targeted radiation with minimal tissue penetration.

TBI complements our Bone Marrow Transplantation service by improving pre-transplant conditioning.

This revolutionary therapy uses tumor biology to direct radiation precisely to tumors in real-time, even as they move. Delivered via the RefleXion® X1 machine, this hybrid technology combines PET imaging with radiation therapy, allowing for the treatment of multiple tumors in a single session.

How it Works

During the therapy, patients receive a single injection of a radiotracer, which creates real-time, detectable emissions from cancer cells. The system’s technology detects these cancer cell emissions and uses them to precisely track and direct radiation to the tumor, transforming cancer cells into biological beacons that direct radiotherapy delivery. 

Benefits

• Ability to precisely treat tumors, even if they are moving
• Combines two proven technologies used for cancer diagnosis and treatment
• Allows for the treatment of multiple tumors in a single session
• Effective for primary and metastatic bone and lung tumors
• Personalized control of radiation delivery
• Enhanced patient safety and convenience
• May reduce radiation exposure and toxicity to healthy tissues

Pluvicto is a groundbreaking treatment option for patients with prostate-specific membrane antigen-positive (PSMA+) metastatic prostate cancer. This innovative targeted therapy eliminates PSMA+ cancer cells throughout the body and offers a clinically proven extension of survival with fewer side effects compared to traditional chemotherapy.

How It Works

Pluvicto is an innovative targeted therapy that targets and eliminates PSMA+ cancer cells found throughout the body, including in the bones, lymph nodes, and visceral metastases. The therapy is administered through an injection, repeating every six weeks for up to six treatments during an outpatient procedure.

Benefits

Opting for Pluvicto treatment at Hackensack Meridian Health offers many advantages for patients:

• Patients gain access to the latest targeted treatment for metastatic prostate cancer right in their local community, making treatment more convenient.
• Pluvicto is an additional option when all other lines of therapy are exhausted Pluvicto is clinically proven to extend survival
• Unlike traditional chemotherapy, Pluvicto has fewer side effects, so patients experience better quality of life during treatment

Talk to your oncologist to see if you’re a candidate for Pluvicto.